Largest Chemicals & Advanced Materials companies in the world by Market Capitalization

This ranking features the largest 1,656 Chemicals & Advanced Materials companies in the world ranked by Market Capitalization, totaling a Market Capitalization of USD 3.48 T, for July 13, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

…

Frequently Asked Questions

Which Chemicals & Advanced Materials company in the world has the highest Market Capitalization ?

The Chemicals & Advanced Materials company in the world with the highest Market Capitalization is ASML Holding N.V. (Amsterdam Stock Exchange: ASML.AS) at USD 314.30 B.

Which Chemicals & Advanced Materials company in the world has the lowest Market Capitalization ?

The Chemicals & Advanced Materials company in the world with the lowest Market Capitalization is Gujarat Raffia Industries Limited (NSE: GUJRAFFIA.NS) at None.

What are the top 10 Chemicals & Advanced Materials companies in the world by Market Capitalization ?

The top 10 Chemicals & Advanced Materials companies in the world by Market Capitalization are ASML Holding N.V., Danaher Corporation, 3M Company, Chugai Pharmaceutical Co., Ltd., Ecolab Inc., Shin-Etsu Chemical Co., Ltd., Compagnie de Saint-Gobain S.A., MERCK Kommanditgesellschaft auf Aktien, PT. Chandra Asri Petrochemical Tbk and Corning Incorporated.

What are the bottom 10 Chemicals & Advanced Materials companies in the world by Market Capitalization ?

The bottom 10 Chemicals & Advanced Materials companies in the world by Market Capitalization are Gujarat Raffia Industries Limited, Omkar Speciality Chemicals Limited, NTR Holding A/S, PT Indo Komoditi Korpora Tbk, PT Kusuma Kemindo Sentosa Tbk, Longevity Health Holdings Inc., Tijaria Polypipes Limited, Protagenic Therapeutics, Inc., Roquefort Therapeutics plc and Vineet Laboratories Limited.